首页|广西某三甲医院2013-2022年恶性肿瘤死亡病例统计分析

广西某三甲医院2013-2022年恶性肿瘤死亡病例统计分析

扫码查看
目的 通过对广西某三甲医院2013-2022年恶性肿瘤的死亡病例进行统计分析,为相关部门制定恶性肿瘤防治策略提供科学依据.方法 选择主要诊断编码在国际疾病分类ICD-10C00-C75和C81-C97原发恶性肿瘤范围内,从广西某三甲医院病案信息系统采集2013年1月1日-2022年12月31日期间出院患者中主要诊断为恶性肿瘤并且离院方式为死亡的信息进行回顾性分析.结果 2013-2022年恶性肿瘤死亡病例共1112例,病死率为1.26%,逐年呈下降趋势,差异具有统计学意义,P<0.05.男性病死率为1.40%,女性病死率为1.10%,不同性别病死率差异具有统计学意义,P<0.05;45~64岁年龄组的死亡患者最多,占48.29%,病死率最高的年龄组为65岁以上年龄组,为1.80%,不同年龄组的病死率差异有统计学意义,P<0.05;前5位死因分别是肺癌269例(24.19%)、肝癌177例(15.92%)、乳腺癌120例(10.79%)、结直肠癌105例(9.44%)和胃癌84例(7.55%).男性死因首位为肺癌176例(26.99%),其次为肝癌145例(22.94%).女性死因首位为乳腺癌120例(26.09%),其次为肺癌93例(20.22%);城镇职工基本医疗保险支付人数为530人(47.66%),居首位;其次为城镇居民基本医疗保险支付人数为236人(21.22%),不同付款方式的恶性肿瘤患者病死率差异具有统计学意义,P<0.05.结论 恶性肿瘤病死率呈明显下降趋势,且男性高于女性,应针对45岁及以上重点人群肺癌、肝癌和结直肠癌的筛查,其中男性重点筛查肺癌、肝癌以及结直肠癌,女性重点筛查乳腺癌、肝癌和结直肠癌,有效、规范和合理开展肿瘤诊疗工作,降低肿瘤发病率和病死率.
Statistical Analysis of Malignant Tumor Deaths in a Three A and Tertiary Hospital in Guangxi from 2013 to 2022
Objectives Through the statistical analysis of the death cases of malignant tumors in a Three A and Tertiary Hospital in Guangxi from 2013 to 2022,this paper provided a scientific basis for relevant departments to formulate malignant tumor prevention and treatment strategies.Methods With the International Classification of Diseases(ICD-10)code as the standard,the primary diagnosis codes were selected in the range of primary malignant tumors C00-C75 and C81-C97.A retrospective analysis was carried out on the data of all patients discharged from hospital from January 1st,2013 to December 31st,2022,who were mainly diagnosed with malignant tumor and died by way of discharge from the medical record information system of a top-three hospital in Guangxi.Results From 2013 to 2022,there were 1112 cases of malignant tumor deaths in the hospital,with a case fatality rate of 1.26%,showing a downward trend year by year(x2=300.05,P<0.001),of which the case fatality rate of men was 1.40%and that of women was 1.10%,and the difference in mortality rates between genders was statistically significant(x2=14.83,P<0.001).In terms of age distribution,the 45-64 age group had the most deaths,accounting for 48.29%,of which the age group with the highest case fatality rate was over 65 years old,which was 1.80%,and the difference in case fatality rate between different age groups was statistically significant(x2=57.74,P<0.001).The leading causes of death were identified as follows:lung cancer(269 cases,24.19%),liver cancer(177 cases,15.92%),breast cancer(120 cases,10.79%),colorectal cancer(105 cases,9.44%),and gastric cancer(84 cases,7.55%).Among male deaths,lung cancer ranked first(176 cases,26.99%),followed by liver cancer(145 cases,22.94%).Among female deaths,breast cancer was the leading cause(120 cases,26.09%),followed by lung cancer(93 cases,20.22%).In terms of payment methods,the majority of malignant neoplasm patients were covered by urban employee basic medical insurance(530 people,47.66%),followed by urban resident basic medical insurance(236 people,21.22%).The differences in mortality rates among different payment methods were statistically significant(x2=239.30,P<0.001).In summary,the hospital experienced a declining trend in the mortality rate of malignant neoplasms from 2013 to 2022.Significant variations in mortality rates were observed based on gender,age group,leading causes of death,and payment methods.These findings highlight the importance of targeted interventions and healthcare policies for specific population groups and conditions.Conclusions The mortality rate of malignant tumor showed a decreasing trend,and the mortality rate of male was higher than that of female,we should focus on the screening of lung cancer,liver cancer and colorectal cancer aged 45 years and above,among which male screening should be focused on lung cancer,liver cancer and colorectal cancer,and female screening should be focused on breast cancer,liver cancer and colorectal cancer,so as to carry out effective,standardized and reasonable cancer diagnosis and treatment,and reduce the incidence and mortality of cancer.

Malignant tumorsDeathEpidemiologyFatal cases

杜梅珍、梁善雄、赵阳、梁桂丹、黄天壬、肖晓兰

展开 >

广西医科大学附属肿瘤医院,广西壮族自治区,南宁市,530021

广西医科大学公共卫生学院,广西壮族自治区,南宁市,530021

恶性肿瘤 死因 流行病学 死亡病例

2019年广西自然科学基金课题项目

2019JJD140017

2024

中国病案
中国医院协会

中国病案

CSTPCD
影响因子:1.197
ISSN:1672-2566
年,卷(期):2024.25(6)